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After the publication of this work [1], we noticed the typo-
graphical errors in Tables 8, 9, 16, and 17: there were
inconsistencies between the ranking of cancer mortality
and incidence and their corresponding figures. Here we
briefly present the results along with the revisions of the
relevant tables since the ranking was corrected while the
figures remained the same as the original.
Tables 1 and 2 represent the ranking of the number of
deaths by cancer site in the world and three selected sub
regions: African Region with a high child and adult mor-
tality (AfrE), European Region with a very low child and
adult mortality (EurA), and South East Asia Region with a
low child and adult mortality (SearB). Lung cancer was
the leading cause of cancer deaths in the world, account-
ing for 17% of total cancer mortality, followed by cancers
of stomach (12% of total), colon and rectum (9%), liver
(9%), and breast (7%). In males, lung, stomach, and liver
cancers were the three most common causes of cancer
deaths. The leading cause of cancer deaths among females
was breast cancer, but lung cancer was already one of the
largest causes of female cancer mortality.
The distribution of common cancer incidence was some-
what similar to that of mortality: lung cancer was the most
common cancer in the world in 2000, accounting for 13%
of total cancer incidence, followed by cancers of colon
and rectum (10% of total), breast (10%), stomach (10%),
and liver (6%) (Table 3). As in mortality distribution,
there is a significant variation in the distribution of site-
specific cancer incidence by region (Table 4). The varia-
tions in the distribution of site-specific new cases of can-
cer by region were also similar to those observed in
mortality distribution.
We regret any inconvenience that this inaccuracy in the
tables might have caused. We wish to thank Dr. Robert
Dubrow of Yale University School of Medicine for bring-
ing this matter to our attention.
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Table 1: Ranking of the global cancer deaths by site, 2000
Site Number of deaths (000s) Proporion of total (%)
Both sexes
Trachea, bronchus, and lung 1,201.1 17.1
Stomach 836.2 11.9
Colon and rectum 607.3 8.7
Liver 605.9 8.6
Breast 468.9 6.7
Oesophagus 431.2 6.1
Lymphomas and multiple myeloma 332.3 4.7
Mouth and oropharynx 319.6 4.6
Prostate 263.6 3.8
Leukaemia 260.1 3.7
Cervix uteri 259.6 3.7
Pancreas 222.6 3.2
Bladder 177.4 2.5
Ovary 128.6 1.8
Corpus uteri 72.9 1.0
Melanoma of the skin 65.1 0.9
Males
Trachea, bronchus, and lung 877.3 22.5
Stomach 512.0 13.2
Liver 414.9 10.7
Colon and rectum 311.8 8.0
Oesophagus 273.6 7.0
Prostate 263.6 6.8
Mouth and oropharynx 222.4 5.7
Lymphomas and multiple myeloma 168.6 4.3
Leukaemia 145.3 3.7
Bladder 123.9 3.2
Pancreas 117.0 3.0
Melanoma of the skin 35.1 0.9
Females
Breast 466.3 14.9
Stomach 324.2 10.4
Trachea, bronchus, and lung 323.8 10.4
Colon and rectum 295.5 9.4
Cervix uteri 259.6 8.3
Liver 191.0 6.1
Lymphomas and multiple myeloma 163.7 5.2
Oesophagus 157.6 5.0
Ovary 128.6 4.1
Leukaemia 114.7 3.7
Pancreas 105.6 3.4
Mouth and oropharynx 97.2 3.1
Corpus uteri 72.9 2.3
Bladder 53.5 1.7
Melanoma of the skin 30.1 1.0BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/20
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Table 2: Ranking of selected regional cancer deaths by site, 2000
WHO sub region
AfrE (high child and adult mortality) EurA (very low child and adult mortality) SearB (low child and adult mortality)
Site Number
of deaths
(000s)
Proportion
of total (%)
Number
of deaths
(000s)
Proportion
of total (%)
Number
of deaths
(000s)
Proportion
of total (%)
Both sexes
Cervix uteri 36.8 12.4 Trachea, bronchus, 
and lung
207.2 19.5 Trachea, bronchus, 
and lung
48.3 16.6
Liver 33.3 11.2 Colon and rectum 141.8 13.3 Liver 36.5 12.5
Breast 23.0 7.8 Breast 92.7 8.7 Breast 29.1 10.0
Mouth and 
oropharynx
21.4 7.2 Prostate 70.2 6.6 Colon and rectum 27.6 9.5
Oesophagus 20.6 7.0 Stomach 66.8 6.3 Mouth and 
oropharynx
18.6 6.4
Prostate 19.2 6.5 Lymphomas and 
multiple myeloma
55.0 5.2 Lymphomas and 
multiple myeloma
15.8 5.4
Lymphomas and 
multiple myeloma
18.8 6.4 Pancreas 53.6 5.0 Cervix uteri 15.4 5.3
Stomach 17.0 5.7 Liver 38.6 3.6 Leukaemia 14.7 5.1
Colon and rectum 14.1 4.8 Bladder 37.6 3.5 Stomach 12.5 4.3
Trachea, bronchus, 
and lung
14.0 4.7 Leukaemia 37.3 3.5 Ovary 8.7 3.0
Leukaemia 11.8 4.0 Oesophagus 29.2 2.7 Prostate 8.1 2.8
Ovary 6.7 2.3 Ovary 25.7 2.4 Pancreas 6.8 2.3
Bladder 6.3 2.1 Mouth and 
oropharynx
24.9 2.3 Bladder 5.8 2.0
Melanoma of the skin 5.3 1.8 Corpus uteri 16.0 1.5 Oesophagus 5.6 1.9
Pancreas 5.2 1.8 Melanoma of the skin 15.5 1.5 Corpus uteri 4.0 1.4
Corpus uteri 1.7 0.6 Cervix uteri 8.3 0.8 Melanoma of the skin 1.7 0.6
Males
Liver 23.5 15.2 Trachea, bronchus, 
and lung
158.0 26.6 Trachea, bronchus, 
and lung
40.8 26.4
Prostate 19.2 12.5 Colon and rectum 72.1 12.1 Liver 25.9 16.7
Mouth and 
oropharynx
14.3 9.3 Prostate 70.2 11.8 Colon and rectum 13.9 9.0
Oesophagus 13.8 8.9 Stomach 38.9 6.5 Mouth and 
oropharynx
13.1 8.4
Lymphomas and 
multiple myeloma
13.7 8.9 Lymphomas and 
multiple myeloma
27.6 4.6 Lymphomas and 
multiple myeloma
9.6 6.2
Stomach 9.8 6.3 Bladder 27.1 4.6 Prostate 8.1 5.3
Trachea, bronchus, 
and lung
9.4 6.1 Pancreas 26.7 4.5 Leukaemia 7.6 4.9
Colon and rectum 8.8 5.7 Liver 25.3 4.3 Stomach 7.1 4.6
Leukaemia 6.9 4.5 Oesophagus 21.4 3.6 Bladder 4.4 2.8
Bladder 4.3 2.8 Leukaemia 20.0 3.4 Pancreas 3.5 2.3
Pancreas 2.7 1.8 Mouth and 
oropharynx
19.2 3.2 Oesophagus 3.3 2.1
Melanoma of the skin 2.2 1.5 Melanoma of the skin 8.3 1.4 Melanoma of the skin 0.7 0.5
Females
Cervix uteri 36.8 26.0 Breast 91.8 19.6 Breast 29.0 21.2
Breast 23.0 16.3 Colon and rectum 69.7 14.9 Cervix uteri 15.4 11.2
Liver 9.8 6.9 Trachea, bronchus, 
and lung
49.2 10.5 Colon and rectum 13.6 10.0
Stomach 7.2 5.1 Stomach 27.9 6.0 Liver 10.6 7.8
Mouth and 
oropharynx
7.1 5.0 Lymphomas and 
multiple myeloma
27.4 5.9 Ovary 8.7 6.3BMC Cancer 2003, 3 http://www.biomedcentral.com/1471-2407/3/20
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Oesophagus 6.8 4.8 Pancreas 26.9 5.8 Trachea, bronchus, 
and lung
7.5 5.5
Ovary 6.7 4.8 Ovary 25.7 5.5 Leukaemia 7.2 5.2
Colon and rectum 5.3 3.7 Leukaemia 17.2 3.7 Lymphomas and 
multiple myeloma
6.1 4.5
Lymphomas and 
multiple myeloma
5.2 3.7 Corpus uteri 16.0 3.4 Mouth and 
oropharynx
5.5 4.0
Leukaemia 4.9 3.5 Liver 13.3 2.8 Stomach 5.5 4.0
Trachea, bronchus, 
and lung
4.5 3.2 Bladder 10.5 2.2 Corpus uteri 4.0 2.9
Melanoma of the skin 3.0 2.1 Cervix uteri 8.3 1.8 Pancreas 3.3 2.4
Pancreas 2.5 1.8 Oesophagus 7.8 1.7 Oesophagus 2.3 1.7
Bladder 2.0 1.4 Melanoma of the skin 7.2 1.5 Bladder 1.4 1.0
Corpus uteri 1.7 1.2 Mouth and 
oropharynx
5.7 1.2 Melanoma of the skin 1.0 0.7
Table 3: Ranking of the global cancer incidence by site, 2000
Site Number of new cases (000s) Proportion of total (%)
Both sexes
Trachea, bronchus and lung 1,305.6 12.7
Colon and rectum 1,045.0 10.2
Breast 1,031.9 10.0
Stomach 973.1 9.5
Liver 626.4 6.1
Prostate 550.2 5.3
Cervix uteri 487.5 4.7
Lymphomas and multiple myeloma 481.1 4.7
Oesophagus 452.7 4.4
Mouth and oropharynx 420.7 4.1
Bladder 382.9 3.7
Leukaemia 364.7 3.5
Corpus uteri 326.3 3.2
Pancreas 226.2 2.2
Ovary 221.3 2.2
Melanoma of the skin 206.7 2.0
Males
Trachea, bronchus and lung 939.9 18.2
Stomach 589.3 11.4
Prostate 550.2 10.6
Colon and rectum 527.8 10.2
Liver 422.0 8.2
Oesophagus 286.5 5.5
Bladder 277.2 5.4
Mouth and oropharynx 267.1 5.2
Lymphomas and multiple myeloma 238.5 4.6
Leukaemia 195.2 3.8
Pancreas 119.3 2.3
Melanoma of the skin 118.2 2.3
Females
Breast 1,031.9 20.1
Colon and rectum 517.3 10.1
Cervix uteri 487.5 9.5
Stomach 383.9 7.5
Trachea, bronchus and lung 365.7 7.1
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Page 5 of 6
(page number not for citation purposes)
Corpus uteri 326.3 6.4
Lymphomas and multiple myeloma 242.6 4.7
Ovary 221.3 4.3
Liver 204.4 4.0
Leukaemia 169.5 3.3
Oesophagus 166.2 3.2
Mouth and oropharynx 153.6 3.0
Pancreas 106.9 2.1
Bladder 105.7 2.1
Melanoma of the skin 88.5 1.7
Table 4: Ranking of the selected regional cancer incidence by site, 2000
WHO sub region
AfrE (high child and adult mortality) EurA (very low child and adult mortality) SearB (low child and adult mortality)
Site Number 
of new 
cases 
(000s)
Proportion 
of total (%)
Site Number 
of new 
cases 
(000s)
Proportion 
of total (%)
Site Number 
of new 
cases 
(000s)
Proportion 
of total (%)
Both sexes
Cervix uteri 67.9 16.4 Colon and rectum 264.7 15.4 Breast 53.9 12.3
Breast 39.8 9.6 Trachea, bronchus 
and lung
227.3 13.2 Trachea, bronchus 
and lung
51.4 11.7
Liver 34.7 8.3 Breast 221.8 12.9 Colon and rectum 44.3 10.1
Prostate 28.2 6.8 Prostate 139.1 8.1 Liver 40.3 9.2
Mouth and 
oropharynx
27.9 6.7 Bladder 86.5 5.0 Cervix uteri 32.8 7.5
Lymphomas and 
multiple myeloma
26.6 6.4 Lymphomas and 
multiple myeloma
80.2 4.7 Mouth and 
oropharynx
25.4 5.8
Oesophagus 21.2 5.1 Stomach 79.6 4.6 Lymphomas and 
multiple myeloma
22.9 5.2
Colon and rectum 20.3 4.9 Corpus uteri 68.3 4.0 Leukaemia 21.5 4.9
Stomach 19.4 4.7 Pancreas 55.5 3.2 Corpus uteri 19.9 4.5
Leukaemia 16.2 3.9 Melanoma of the skin 49.1 2.8 Ovary 18.1 4.1
Trachea, bronchus 
and lung
14.8 3.6 Leukaemia 48.6 2.8 Stomach 15.3 3.5
Ovary 12.2 2.9 Liver 40.1 2.3 Prostate 13.4 3.1
Bladder 10.7 2.6 Ovary 39.4 2.3 Bladder 10.1 2.3
Melanoma of the skin 7.7 1.8 Mouth and 
oropharynx
38.6 2.2 Pancreas 7.2 1.7
Corpus uteri 6.0 1.4 Oesophagus 31.2 1.8 Oesophagus 6.2 1.4
Pancreas 5.4 1.3 Cervix uteri 18.8 1.1 Melanoma of the skin 3.1 0.7
Male Male Male
Prostate 28.2 14.8 Trachea, bronchus 
and lung
172.0 19.6 Trachea, bronchus 
and lung
43.1 22.0
Liver 23.6 12.4 Prostate 139.1 15.9 Liver 28.6 14.6
Lymphomas and 
multiple myeloma
18.6 9.8 Colon and rectum 133.8 15.3 Colon and rectum 21.4 11.0
Mouth and 
oropharynx
16.5 8.7 Bladder 65.1 7.4 Mouth and 
oropharynx
16.0 8.2
Oesophagus 14.1 7.4 Stomach 45.6 5.2 Prostate 13.4 6.9
Colon and rectum 12.0 6.3 Lymphomas and 
multiple myeloma
39.3 4.5 Lymphomas and 
multiple myeloma
13.3 6.8
Stomach 10.9 5.8 Mouth and 
oropharynx
28.7 3.3 Leukaemia 10.7 5.5
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Trachea, bronchus 
and lung
9.8 5.2 Pancreas 27.4 3.1 Stomach 8.6 4.4
Leukaemia 9.2 4.9 Liver 26.1 3.0 Bladder 7.7 3.9
Bladder 7.3 3.8 Leukaemia 25.6 2.9 Oesophagus 3.8 1.9
Melanoma of the skin 3.4 1.8 Oesophagus 22.8 2.6 Pancreas 3.7 1.9
Pancreas 2.8 1.5 Melanoma of the skin 22.6 2.6 Melanoma of the skin 1.2 0.6
Female Female Female
Cervix uteri 67.9 30.2 Breast 221.8 26.2 Breast 53.9 22.3
Breast 39.8 17.7 Colon and rectum 131.0 15.4 Cervix uteri 32.8 13.6
Ovary 12.2 5.4 Corpus uteri 68.3 8.1 Colon and rectum 22.8 9.4
Mouth and 
oropharynx
11.4 5.1 Trachea, bronchus 
and lung
55.3 6.5 Corpus uteri 19.9 8.2
Liver 11.1 4.9 Lymphomas and 
multiple myeloma
40.9 4.8 Ovary 18.1 7.5
Stomach 8.4 3.7 Ovary 39.4 4.6 Liver 11.7 4.8
Colon and rectum 8.2 3.7 Stomach 33.9 4.0 Leukaemia 10.8 4.5
Lymphomas and 
multiple myeloma
8.0 3.6 Pancreas 28.1 3.3 Lymphomas and 
multiple myeloma
9.6 4.0
Oesophagus 7.2 3.2 Melanoma of the skin 26.5 3.1 Mouth and 
oropharynx
9.4 3.9
Leukaemia 7.0 3.1 Leukaemia 23.0 2.7 Trachea, bronchus 
and lung
8.3 3.4
Corpus uteri 6.0 2.7 Bladder 21.4 2.5 Stomach 6.7 2.8
Trachea, bronchus 
and lung
5.0 2.2 Cervix uteri 18.8 2.2 Pancreas 3.6 1.5
Melanoma of the skin 4.3 1.9 Liver 14.0 1.7 Oesophagus 2.5 1.0
Bladder 3.4 1.5 Mouth and 
oropharynx
9.9 1.2 Bladder 2.4 1.0
Pancreas 2.6 1.2 Oesophagus 8.4 1.0 Melanoma of the skin 1.9 0.8
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